Contribute Try STAT+ Today

Top of the morning to you, and a fine one it is. We enjoy this saying, but it is very true today. A delicious breeze and clear, blue skies are enveloping the buzzing Pharmalot campus this morning. Despite the gorgeous weather, however, there is much to keep us in front of the laptop: deadlines, online calls, to-do lists that grow faster than weeds. This sounds familiar, yes? So time to get started with a few tidbits. Have a wonderful day, and drop us a line if you hear anything interesting. …

Leaders of the world’s largest economies back “voluntary licensing” of Covid-19 vaccine patents, watering down a U.S. push for waivers and earlier commitments to supply more funds to the World Health Organization, Reuters reports. The draft document lists commitments of G20 nations and other countries and is to be adopted on Friday at a Global Health Summit in Rome, one of this year’s major events to coordinate global actions against the pandemic. The draft, which is still subject to changes, is the result of a compromise among experts from G20 nations, which remain divided over the waiving of intellectual property rights for Covid-19 vaccines.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.